Biopharmaceutics, a critical facet of cheminformatics, delves into the interface between pharmaceuticals and the human body. It navigates the complex journey of drugs from their administration to their therapeutic effect. In this interdisciplinary field, advanced computational methods play a pivotal role in understanding the intricate interactions between drugs and biological systems.
Cheminformatics techniques, such as molecular modeling and bioinformatics, empower researchers to analyze and optimize drug formulations, enhancing their bioavailability and efficacy. By leveraging computational tools, scientists can predict pharmacokinetic profiles, absorption rates, and distribution patterns of pharmaceutical compounds, streamlining the drug development process.
The synergy between cheminformatics and biopharmaceutics opens new frontiers in personalized medicine, allowing for tailored drug design based on individual patient characteristics. This convergence of data-driven insights and pharmaceutical science holds the promise of revolutionizing how we approach drug discovery and development, ultimately contributing to more effective and targeted therapies.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia